Vestmark Advisory Solutions, Inc. Immuno Gen, Inc. Transaction History

Vestmark Advisory Solutions, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$4.48 - $6.47 $1,756 - $2,536	392 Added 1.6%	24,892 $119,000
Q2 2022 Aug 04, 2022	BUY	$3.15 - $5.76 $31,991 - $58,498	10,156 Added 70.8%	24,500 $110,000
Q1 2022 Apr 27, 2022	SELL	$4.26 - $7.48 $766 - $1,346	-180 Reduced 1.24%	14,344 $68,000
Q4 2021 Jan 31, 2022	SELL	$4.75 - $7.5 $1,895 - $2,992	-399 Reduced 2.67%	14,524 $108,000
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $968 - $1,271	193 Added 1.31%	14,923 $85,000
Q2 2021 Aug 09, 2021	SELL	$5.79 - $8.6 $94,759 - $140,747	-16,366 Reduced 52.63%	14,730 $97,000
Q1 2021 May 10, 2021	BUY	$6.5 - $10.53 $105,007 - $170,112	16,155 Added 108.13%	31,096 $252,000
Q4 2020 Feb 04, 2021	SELL	$3.7 - $7.66 $1,346 - $2,788	-364 Reduced 2.38%	14,941 $96,000
Q3 2020 Oct 19, 2020	SELL	$3.45 - $4.89 $445 - $630	-129 Reduced 0.84%	15,305 $55,000
Q2 2020 Aug 13, 2020	SELL	$3.32 - $5.34 $6,563 - $10,557	-1,977 Reduced 11.35%	15,434 $71,000
Q1 2020 May 06, 2020	BUY	$2.12 - $6.8 $36,911 - $118,394	17,411 New	17,411 $59,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $5.8 $38,398 - $98,982	-17,066 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$2.22 - $3.39 $1,909 - $2,915	-860 Reduced 4.8%	17,066 $41,000
Q2 2019 Aug 20, 2019	BUY	$1.8 - $3.3 $626 - $1,148	348 Added 1.98%	17,926 $39,000
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $42,362 - $103,885	17,578 New	17,578 $48,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.